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a b s t r a c t
Simian hemorrhagic fever virus is an arterivirus that naturally infects species of African nonhuman
primates causing acute or persistent asymptomatic infections. Although it was previously estimated that
1% of baboons are SHFV-positive, more than 10% of wild-caught and captive-bred baboons tested were
SHFV positive and the infections persisted for more than 10 years with detectable virus in the blood
(100–1000 genomes/ml). The sequences of two baboon SHFV isolates that were ampliﬁed by a single
passage in primary macaque macrophages had a high degree of identity to each other as well as to the
genome of SHFV-LVR, a laboratory strain isolated in the 1960s. Infection of Japanese macaques with
100 PFU of a baboon isolate consistently produced high level viremia, pro-inﬂammatory cytokines,
elevated tissue factor levels and clinical signs indicating coagulation defects. The baboon virus isolate
provides a reliable BSL2 model of viral hemorrhagic fever disease in macaques.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Simian hemorrhagic fever virus (SHFV) was ﬁrst isolated in 1964
and shown to be the causative agent of fatal hemorrhagic fever
outbreaks in macaque colonies in the United States and the USSR
(Allen et al., 1968; Palmer et al., 1968; Tauraso et al., 1968; Shevtsova,
1969; Lapin and Shevtsova, 1971). Mortality approached 100% by
2 weeks after infection (Tauraso et al., 1968; Gravell et al., 1980). The
clinical signs of an SHFV infection in macaques closely resemble those
of other hemorrhagic fever viruses such as Ebola, Marburg and Lassa
viruses (Mahanty and Bray, 2004; Bray, 2005). Viral hemorrhagic fever
disease is characterized by the release of pro-inﬂammatory cytokines
from infected macrophages (MΦs) and dendritic cells (DCs) that
induces tissue factor production and subsequent disseminated intra-
vascular coagulopathy (Geisbert et al., 2003b; Bray, 2005; Levi et al.,
2006). Previous SHFV outbreaks in primate facilities are thought to
have been initiated by inadvertent blood-to-blood transmission from a
persistently infected African nonhuman primate (NHP) to a macaque
(London, 1977). In the case of an outbreak at NIH, virus was likely
transmitted by the use of the same needle for tattooing or tuberculosis
testing of multiple NHPs of African and Asian origin (Allen et al., 1968;
Palmer et al., 1968; Tauraso et al., 1968). SHFV is typically transmitted
between African NHPs during ﬁghting but can spread efﬁciently
among macaques by both direct and indirect contact (London, 1977;
Renquist, 1990).
SHFV is a member of the Family Arteriviridae, which also includes
equine arteritis virus (EAV), porcine reproductive and respiratory
syndrome virus (PRRSV), and lactate dehydrogenase-elevating virus
(LDV), in the order Nidovirales (Snijder and Kikkert, 2013). A related
virus, wobbly possum virus, was recently identiﬁed (Dunowska et al.,
2012; Snijder and Kikkert, 2013). Arteriviruses typically have restricted
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cell tropisms and host ranges; MΦs and DCs are infected by EAV in
horses and donkeys, by PRRSV in pigs, by LDV in mice and by SHFV
in several species of African NHPs and macaques but not in
chimpanzees or humans (Snijder and Meulenberg, 1998). EAV and
PRRSV infections can cause diseases in susceptible host species
characterized by fever, anorexia, tissue necrosis, inﬂammation of
the respiratory tract and reproductive failure, such as spontaneous
abortions or delivery of weak offspring (Snijder and Kikkert, 2013).
In mice, LDV typically causes lifelong, asymptomatic, persistent
infections that are characterized by increased serum levels of lactate
dehydrogenase (Brinton and Plagemann, 1983; Snijder and Kikkert,
2013). Due to the signiﬁcant agricultural impact of diseases caused
by EAV and PRRSV, the majority of research on arteriviruses has
been focused on these two viruses.
Only a single SHFV isolate, LVR v42-0/M6941, obtained from a
stump-tailed macaque that died of SHF during the Bethesda 1964
SHFV epizootic (Tauraso et al., 1968), survived from earlier studies
of SHFV and was available from the American Type Culture
Collection (ATCC). Although the origin of this virus is not known
for certain, patas monkeys (Erythrocebus patas) housed in the same
facility were later found to be persistently infected with SHFV and
to be the source of the SHFV infecting new rhesus macaques in
subsequent epizootics in the same facility (London, 1977).
Although SHFV LVR efﬁciently induced SHF disease in macaques
in the 1960s (Tauraso et al., 1968), in a recent study, no correlation
was observed between virus dose (ranging from 50 to
500,000 PFU/ml) and efﬁciency of induction of fatal hemorrhagic
fever disease in macaques (Johnson et al., 2011). Bacterial sepsis
was detected in 75% (12 of 16) of the SHFV-infected animals that
did not survive suggesting that this played a major role in
mortality. Genome sequences for a number of divergent strains
of SHFV have recently been reported (Lauck et al., 2011; 2013).
However, viruses containing these genomes have not yet been
biologically characterized.
In the present study, a survey for SHFV in wild caught and captive
baboons was done using two RT-PCR assays targeting conserved
regions of the SHFV genome. The data indicated that more than 10%
of both populations were SHFV-infected compared to the previous
estimate of 1% (London, 1977). Data from serial archival samples used
for testing indicated that animals remained infected for at least 10
years. Persistently infected baboons had very low levels of viremia.
SHFV isolates from two persistently infected baboons (410 years)
were ampliﬁed once in primary macaque MΦs and subsequently
sequenced. The genome sequences of these isolates were very similar
both to each other and to that of SHFV LVR, an isolate from the 1960s
from a macaque that may have been infected with virus originating
from a patas monkey. Intravenous injection of Japanese macaques
(Macaca fuscata) with 100 PFU of one of the baboon SHFV isolates
resulted in consistent induction of severe hemorrhagic fever disease,
characterized by high level viremia, the production of pro-
inﬂammatory cytokines, elevation of tissue factor and coagulopathy,
in each of four infected animals. Cells co-expressing viral nonstructural
proteins and the MΦmarker CD68 were detected in liver and spleen.
Sepsis was not identiﬁed in any of the macaques. SHFV infection in
macaques has been proposed as a BSL2 model for viral hemorrhagic
fever disease (Johnson et al., 2011). Using the new baboon isolate of
SHFV and Japanese macaques, we demonstrated consistent disease
induction in the absence of bacterial infection with a low dose virus
inoculum.
Results
Survey of wild-caught and current baboons at the Southwest National
Primate Research Center
Because we required PBMCs from SHFV-negative baboons
for studies comparing MØ and DC responses to experimental
Baboon ID     Capture/Birthdate          Sampling Date     Nucleocapsid          Helicase  
B11661            4/1/1990   12/1/2000  +   + 
      9/28/2007  +   + 
      1/19/2010  +   + 
B11662            1/1/1992   11/4/1999  +   + 
      7/29/2003  +   + 
      8/11/2005  +   + 
      1/19/2010  +   + 
B19927            2/10/2004  4/7/2008  +   + 
      4/21/2010  +   + 
      10/19/2010  +   + 
B25360            9/5/2004   10/20/2008  +   + 
      4/21/2010  +   + 
      10/19/2010  +   + 
Fig. 1. Detection of SHFV RNA by RT-PCR in baboon sera. RNA isolated from 100 μl of baboon serum was analyzed by one-step RT-PCR. Pairs of primers were designed to
amplify (A) nucleocapsid or (B) helicase regions of the SHFV genome. RNA extracted from an aliquot of a stock pool of SHFV-LVR containing 107 PFU/ml of virus was used as
the positive control and nuclease-free water was used as the negative control. PCR products were separated on 1% agarose gels. Lane 1, SHFV-LVR RNA; lane 2, water; lane 3,
SHFV-positive baboon serum; and lane 4, SHFV-negative baboon serum. The results shown are representative of the results obtained for sera from a total of 33 SHFV-positive
and 166 SHFV-negative baboons. (C) Assay of SHFV RNA in multiple archived samples from the same animal. RNA extracted from 100 μl of an archived serum sample was
tested for SHFV using both RT-PCR assays.
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SHFV infections (Vatter and Brinton, 2014) and it had previously
been reported that 1% of baboons were SHFV positive (London,
1977), two RT-PCR assays were developed to stringently detect
SHFV in serum from positive animals. Primer sets were designed
to target sequences in the SHFV-LVR nucleocapsid and helicase
genes that are well conserved among different arteriviruses. The
primers were ﬁrst tested using RNA extracted from an SHFV-LVR
pool made from a three times plaque puriﬁed virus stock. A single
300 bp PCR product was detected with the nucleocapsid primers
(Fig. 1A, lane 1). With the helicase primer set, the expected 700 bp
PCR product and also a second unexpected 350 bp product were
observed indicating the presence of defective genomes with an
internal deletion in the helicase region in the LVR pool (Fig. 1B,
lane 1). No PCR products were detected in the RNA-free water
lanes (lane 2, Fig. 1A and B). The ability of the two RT-PCR assays to
detect SHFV RNA in NHP sera was next tested using a single
archived serum sample from each of 120 different wild-caught
baboons introduced into the colony at the Southwest National
Primate Research Center between 1981 and 1997. RNA from each
serum sample was isolated and separately ampliﬁed by RT-PCR
with each of the two primer sets. PCR bands of the expected sizes
were detected for 17 of the 120 samples in both the nucleocapsid
and helicase assays (lane 3, Fig. 1A and B, data not shown).
However, the additional 350 bp product detected with SHFV LVR
RNA in the helicase assay was not detected in helicase assays done
on sera from the 17 positive baboons (lane 4, Fig. 1A and B, data
not shown). No PCR bands were detected for the remaining 103
baboon serum samples with either assay (data not shown). All 17
of the positive wild caught animals were Olive baboons (Papio
hamadryas anubis). Two of the 26 male samples and 15 of the 94
female samples were positive. The data indicate that a total of
14.2% of the 120 wild-caught baboons that entered the colony
during this 16 year period were SHFV positive.
The RT-PCR assays were then used to test a plasma sample from
each baboon from the Southwest National Primate Research
Center colony used to collect whole blood samples for differentia-
tion of MΦs and mDCs (Vatter and Brinton, 2014). The animals
sampled were ones that were in the clinic for their yearly check-up
or for treatment of lacerations due to ﬁghting between animals
housed together and therefore did not represent a random
sampling of the entire colony. Of the 85 colony-born baboons
tested (18 females and 67 males), 16 (19%) were positive by both
the nucleocapsid and helicase assays (data not shown). Two of the
positive animals were females and 14 were males. The helicase
assays detected only the 700 bp band. Eight of the colony-born,
SHFV-positive animals were Olive baboons (P. hamadryas anubis),
6 were Olive/Yellow hybrids (P. hamadryas anubis/Papio hamadryas
cynocephalus), one was a Hamadryas (Sacred) baboon (Papio
hamadryas) and one was a Chacma/Olive hybrid (Papio ursinus/P.
hamadryas anubis). The ages of the positive animals ranged from
8 to 23 years. The data indicated that SHFV is being transmitted
between baboons within the colony.
The availability of archived samples for four of the living
animals found to be virus positive allowed analysis of the length
of time baboons could remain SHFV-positive. Serial archived
samples were available for two of the wild caught animals found
to be SHFV positive in the initial survey. Each of two archived
samples from B11661 and each of three samples from B11662, as
well as samples collected in 2010, were positive for SHFV RNA
(Fig. 1C). Both B11661 (born in 1990) and B11662 (born in 1992)
were from Kenya and 11661 is known to have come from the
Kajiado region of south central Kenya. These two animals were
housed together at the US Naval Research Unit in Cairo from 1992
to 1994 and also from January 1994 through April 1996 at the
Southwest Foundation for Biomedical Research (which became the
Southwest National Primate Research Center in 1999). The
sequential identiﬁcation numbers were given to these two animals
upon entry into the US colony in 1994. Serial archived serum
samples were also available for two colony-bred animals found to
be positive in 2010 during opportunistic sampling. All of the
archived samples from both B19927 and B25360 were positive
for SHFV RNA (Fig. 1C).
Sequence analysis of baboon SHFV isolate genomes
To semi-quantify the SHFV RNA present in the baboon serum
samples, RNA isolated from 100 µl of B15701, B14815, B11661 or
B11662 sera was serially diluted and analyzed with the nucleo-
capsid region RT-PCR assay. The B15701 and B14815 sera con-
tained 102 genome copies/ml while the B11661 and B11662 sera
contained 103 genome copies/ml (data not shown). These data
indicated that the virus levels in the blood of persistently infected
baboons were low. To analyze the viral genomic sequence, serum
samples (200 μl) were ﬁrst ﬁltered to remove bacteria and then
virus particles were concentrated by ultracentrifugation. The pellet
was treated with RNase and DNase and then nucleic acid was
extracted and subjected to 454 sequencing as described in Materi-
als and methods. The reads were aligned with the SHFV LVR
sequence (accession number AF180391.2). The genome coverage
obtained was very low (15% or less). The two samples with higher
copy numbers (B11661 and B11662) gave the highest levels of
coverage. Sequences for primate viruses, including Torque teno
virus and several primate herpesviruses as well as bacteriophages,
such as Bacillus phage SPO1 and Prochlorococcus phage P-SSM2,
were detected in high abundance. It was expected that the
genomes of these other infectious agents outcompeted the SHFV
genome for the random 454 primer sets.
To increase the amount of SHFV RNA available for sequencing
and reduce the levels of other infectious agents, virus from
persistently infected baboon sera was ampliﬁed by a single
passage in primary macaque MΦs. Serum (200 ml) from 4 baboons
(B11661, B11662, B19927 and B25360) was separately used to
infect rhesus macaque MΦ cultures. Cells from a different maca-
que were used for each baboon sample. Culture ﬂuids were
collected at 24 h intervals and tested by RT-PCR. By 120 h after
infection, both the nucleocapsid and helicase RT-PCR assays
detected the presence of SHFV RNA in all of the culture ﬂuids
(data not shown). The culture ﬂuids were also analyzed for
infectivity by plaque assay on MA104 cells. Virus titers for the
B11661 and B11662 120 h culture ﬂuids were 104 PFU/ml and for
B19927 and B25360 120 h culture ﬂuids were 103 PFU/ml.
Rhesus macaque MΦ-ampliﬁed B11662 and B11661 culture
ﬂuids (1 ml) were then processed as described above and analyzed
by 454 sequencing. These two isolates were chosen for sequencing
because they were from animals infected for more than 10 years
and contained 10 fold higher infectivity titers than the other two
isolate samples. Nearly complete sequences for both (B11662 94.8%
and B11661 99.7% coverage of LVR) and a low background of other
sequences were obtained. Compared to the SHFV-LVR sequence
(accession number AF180391.2), the sequence of the B11661
isolate varied at 7 nt positions while the genome of the B11662
isolate varied at 10 nt positions (Table 1). Most of the changes in
B11662 differed from those in B11661. The partial B11661 and
B11662 genomic sequences have been deposited in GenBank
under accession numbers KM655765 and KM655766, respectively.
The very high sequence conservation observed between the
genomes of two SHFV isolates obtained from baboons that were
each persistently infected for more than 10 years and also between
the genomes of these two baboon viruses and SHFV-LVR which
was isolated in the 1970s was unexpected.
H.A. Vatter et al. / Virology 474 (2015) 186–198188
Infection of Japanese macaques with a baboon SHFV isolate
In studies conducted in the 1960s, SHFV LVR efﬁciently induced
fatal hemorrhagic fever disease in rhesus macaques (Tauraso et al.,
1968). However, in a recent study in rhesus macaques, inefﬁcient
disease induction was observed with a current stock of SHFV LVR
(Johnson et al., 2011). Because of the high sequence similarity
between the B11661 and B11662 baboon isolates and LVR, we
postulated that the baboon isolates would have a virulence
phenotype similar to LVR in macaques. The baboon SHFV isolates
had undergone only a single tissue culture passage in primary
macaque MΦ while LVR had been passaged multiple times in
culture (Tauraso et al., 1968; Johnson et al., 2011) and the results
obtained with the helicase RT-PCR assay (Fig. 1) indicated that
defective genomes, which would be expected to reduce virulence,
were still present in our LVR stock after three serial plaque
puriﬁcations.
In the 2011 macaque infection study performed with SHFV LVR,
bacterial sepsis was observed in 75% of the fatal cases (Johnson
et al., 2011). The authors hypothesized that virus-induced immu-
nosuppression led to the development of sepsis in animals that
had existing or opportune bacterial infections. The presence of
bacterial sepsis in many of the animals made it difﬁcult to
discriminate the relative contributions of the SHFV infection and
of the bacterial infection to the host response parameters mea-
sured. To try to avoid bacterial co-infection, healthy animals from a
Japanese macaque (JM) colony at the Oregon National Primate
Research Center were used to test the ability of the B11661 isolate
to induce hemorrhagic disease. The B11661 isolate was chosen
because a complete coding region sequence was obtained for this
isolate. Although data on SHFV infections in several macaque
species have been previously reported (rhesus, cynomolgus and
stump-tailed) (Palmer et al., 1968; London, 1977; Johnson et al.,
2011), no data on SHFV infections in JMs has been reported. Four
animals were infected in two experimental cohorts, each com-
prised of two animals. Each animal was injected intravenously
with 100 PFU of macaque MΦ-ampliﬁed SHFV B11661 diluted in
PBS. The ﬁrst two animals (JM-23333 and JM-24054) developed
fever and lethargy by 3 days post-infection (dpi). By 7 dpi, one
macaque (JM-23333) was febrile, lethargic and anorexic and was
euthanized. Because of the possibility that the non-speciﬁc clinical
signs noted in JM-23333 could have been associated with bacterial
sepsis in addition to SHFV infection, the second macaque
(JM-24054) was treated with an antibiotic on day 9. At 13 dpi,
JM-24054 displayed severe hemorrhagic fever disease signs that
reached a clinical score of 10 and was euthanized (Table 2).
The two animals in the second cohort (JM-22015 and JM-
23328) were prophylactically treated with antibiotic prior to
infection with the SHFV B11661. Both of these animals developed
fever by 3 dpi and displayed clinical signs of hemorrhagic fever
disease, such as fever, epistaxis, petechiae and subcutaneous
edema by 8 dpi and were humanely euthanized on day 9 due to
clinical scores of 10 or greater (Table 2). At necropsy, no evidence
of bacterial sepsis was detected in any of the four SHFV B11661
infected animals.
Host responses to SHFV infection
Plasma and PBMC samples were collected daily from the ﬁrst
set of animals and every other day from the second set. The every
other day collection schedule allowed larger samples to be
obtained. High levels of infectious virus were detected in plasma
Table 1
Variation of two baboon isolates compared to the SHFV LVR sequence.
Position B11661 B11662 SHFV-LVR Amino acid change Gene
26 G C C Non-coding 50UTR
151 A G A Non-coding 50UTR
618 G A G Glu to Lys nsp1α
619 A G A Glu to Gly nsp1α
4928 G A G Silent nsp4
7965 T C T Leu to Pro nsp9
9910 G T G Silent nsp11
10750 G A G Silent nsp12
12408 T C T Silent GP40
13597 A T T Val to Glu GP3
Silent GP4
13604 A G G Silent GP3
Glu to Lys GP4
13605 C A A Asp to His GP3
Glu to Ala GP4
13606 G A A Asp to Ser GP3
Silent GP4
14032 T T C Pro to Ser GP5
Ser to Phe GP5a
14736 A G A Silent GP5
15278 C T T Silent GP6
Table 2
Summary of experimental SHFV infection studies.
Animal ID# Virus infection: 100
plaque forming units
(PFU) intravenously
Prothrombin time
(PT) seconds
(pre-infection)
Prothrombin time
(PT) seconds
(euthanasia)
Activated partial
thromboplastin time
(PTT) seconds
(pre-infection)
Activated partial
thromboplastin time (PTT)
seconds (euthanasia)
Survival (days)
post-SHFV
infection
Clinical signs
Cohort 1
JM-23333 SHFV B11661 NA NA NA NA 7 Fever, lethargy,
anorexic, increased
respiratory rate
JM-24054 SHFV B11661 NA NA NA NA 13 Fever, diarrhea,
scrotal edema,
petechiae,
epistaxis,
Cohort 2
JM-22015 SHFV B11661 10.5 23.0 29.4 48.8 9 Fever, petechiae
and periocular and
scrotal edema
JM-23328 SHFV B11661 11.5 19.5 32.4 54.8 9 Fever, petechiae
and periocular
edema
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Fig. 2. Analysis of SHFV replication kinetics, cytokine production and tissue factor expression in Japanese macaques. (A) Virus infectivity titers in plasma. Plasma samples
collected at the indicated times after infection were titrated for infectivity by plaque assay in MA104 cells. Each data point is the average of duplicate titrations. (B) Viral RNA
copy numbers in PBMCs. Total cell RNA was extracted from PBMCs collected at the indicated times after infection and plus-sense, genome and subgenomic viral RNA was
ampliﬁed by real-time RT-PCR and quantiﬁed using a standard curve generated with a known concentration of viral RNA. (C, D) Relative quantiﬁcation (RQ) of intracellular
IFNβmRNA in PBMCs by real-time quantitative RT-PCR. PBMC RNAwas used to measure IFNβmRNA levels. IFNβmRNA levels are expressed as the fold change in the levels of
IFNβ mRNA in PBMCs from an infected animal versus the level in the same animal at day zero. The amount of IFNβ mRNA in each sample was normalized to the level of 18S
rRNA in the same sample. Values shown are the averages of assays done in triplicate. Error bars represent standard error (E–I) IFNα and pro-inﬂammatory cytokine levels in
the plasma were quantiﬁed by multiplexed ELISA. Values shown are the averages of assays done in triplicate. Error bars represent standard deviation. (J) Tissue factor
expression in PBMCs collected on different days after infection was analyzed by Western blotting using anti-tissue factor antibody. Actin was used as a loading control.
Representative gels are shown.
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from all four animals by plaque assay on MA104 cells by 2 dpi, and
the levels remained high (Fig. 2A), which was in stark contrast to
the lack of virus detection in plasma at later times after infection
in a previous study (Johnson et al., 2011). Intracellular viral RNA
levels in PBMCs collected at different times after infection were
analyzed by qRT-PCR using primers targeting the nucleocapsid
region. The nucleocapsid region primers detect both genomic and
subgenomic intracellular viral RNAs. Peak viral RNA levels were
detected between 4 and 6 days after infection and remained
elevated (Fig. 2B).
As one approach to monitoring the host antiviral response,
IFNβ mRNA levels in PBMCs were measured by qRT-PCR. At early
times after infection, IFNβ mRNA expression levels increased by
only low amounts in three of the four animals (JM-24054, JM-
23333, and JM-23328) and decreased in the fourth (JM-22015).
However, at the time that severe disease signs were observed,
PBMC IFNβ mRNA levels were greatly increased for two animals
but greatly decreased for the other two (Fig. 2C and D). IFNα
protein levels in plasma were quantiﬁed by ELISA. Peak plasma
levels of IFNα protein were observed at 2 dpi for all four animals
but the levels rapidly declined thereafter (Fig. 2E). Pro-
inﬂammatory cytokine levels in plasma were analyzed with a
multiplexed ELISA as described inMaterials and methods. Increased
levels of IL-6, MIP-1α, MIP-1β and TNFα were detected starting at
2 dpi in the plasma of all four of the infected animals (Fig. 3F–I).
No increase in IL-1β, IL-10 or IL-12/23 (p40) levels was detected in
any of the plasma samples (data not shown). The data support the
hypothesis that the production of pro-inﬂammatory cytokines is a
major contributor to SHFV-induced pathology.
Disseminated intravascular coagulopathy is one of the hall-
marks of viral hemorrhagic fever disease. Data from attempts to
measure coagulation parameters on samples from the ﬁrst cohort
using commercially available human-speciﬁc kits were inconclu-
sive likely due to the small volumes of the daily blood samples.
However, data was obtained with the larger samples collected
from the second cohort. Speciﬁcally, JM-22015 and JM-23328
exhibited marked defects in coagulation with prothrombin time
(PT) starting at 10.5 s and 11.5 s, respectively, prior to infection and
reaching 23.0 s and 19.5 s, respectively, at the time of euthanasia
(Table 2). A similar pattern was observed for activated partial
thromboplastin times (APTT), with pre-infection sample values of
29.4 s and 32.4 s, respectively, and values at the time of euthanasia
reaching 48.8 s and 54.8 s, respectively (Table 2).
Disseminated intravascular coagulopathy in Ebola virus
infected macaques is characterized by coagulation defects initiated
by increased expression of tissue factor on monocytic cell surfaces
induced by pro-inﬂammatory cytokine production (Bray, 2005).
Lysates of PBMCs obtained from the infected animals were
analyzed by Western blotting using an anti-human tissue factor
antibody. Tissue factor was detected by 8–9 dpi (Fig. 2J). The
detection of tissue factor in PBMCs at the time that clinical signs of
coagulopathy (petechiae and epistaxis) were also observed was
consistent with the development of disseminated intravascular
coagulopathy (Table 2).
Pathological ﬁndings associated with SHFV infection
Gross and histologic lesions were generally similar to those
described previously (Allen et al., 1968; Abildgaard et al., 1975;
Renquist, 1990; Zack, 1993; Johnson et al., 2011). At necropsy,
consistent ﬁndings in all four animals included splenomegaly, as
well as petechial and ecchymotic hemorrhages in varied and
multiple tissues. The spleens were pale and markedly to severely
enlarged with tense, smooth capsules and rounded margins. On
the sectioned surface, there was expansion of the red pulp
(Fig. 3A) and two animals (JM-23333 and JM-24054) exhibited
attenuation of the white pulp. Hemorrhages were observed in the
skin, at venipuncture sites, and also in the subcutis, sclera, base of
the tongue, spleen, liver, kidney, lung, myocardium, pancreas,
cervical spinal cord, trachea, different lymph nodes, mucosa of
the stomach, duodenum, jejunum and the muscular tunic of the
cecum. Mucosal hemorrhage involving the cranial-most segment
of the duodenum was noted in two animals (JM-24054 and JM-
22015) (Fig. 3B). The key histologic feature in all animals was
lymphoid necrosis involving the spleen, lymph nodes, gut-
associated lymphoid tissue (GALT) and thymus (Fig. 3C). Splenic
lesions included lymphoid necrosis of splenic follicles, mantle and
marginal zones, and periarteriolar lymphoid sheaths (Fig. 3D).
Hemorrhages were also present within and surrounding the
marginal zone (perifollicular hemorrhage) and expansion of the
red pulp with an eosinophilic coagulum and ﬁbrin was observed
(Fig. 3D–F). Fibrin strands are stained purple by the phospho-
tungstic acid hematoxylin histochemical procedure (Fig. 3F). Mod-
erate to severe lymphoid necrosis was observed in the cortex of
the thymus. The thymic medulla was less affected. All lymph
nodes examined demonstrated mild to moderate lymphoid necro-
sis. Generally, the follicular germinal centers were more affected
than the paracortical regions or medullary cords. A minimal to
mild degree of lymphoid necrosis affecting the GALT was noted.
Sections of tonsil were available for evaluation in three of the four
animals and all exhibited lymphoid necrosis.
Other changes included mild hepatic lipidosis in two animals
(JM-22015 and JM-23333) and mild hepatocellular degeneration
and necrosis in three animals (JM-22015, JM-23328, and JM-
24054). One animal (JM-24054) demonstrated minimal lympho-
histiocytic and neutrophilic hepatitis. Another animal (JM-23328)
had random, multifocal mild to moderate hepatic inﬁltrates
composed of lymphocytes, histiocytes, plasma cells and neutro-
phils. Marked hepatic amyloid deposits in one animal (JM-23333)
hampered detection of subtle microscopic changes. Renal tubular
degeneration and necrosis were present in all animals and varied
in degree from minimal to moderate. Mild renal tubular protein
was present in one animal (JM-24054). A lymphohistiocytic inter-
stitial pneumonia was also present in all of the animals. One
animal (JM-24054) had marked interstitial pneumonia and also
exhibited vasculitis of the pulmonary vasculature. All animals had
minimal lymphocytic or lymphohistiocytic inﬁltrates in the myo-
cardium. Three animals showed minimal lymphocytic or lympho-
histiocytic inﬂammation in various regions of the central nervous
system. One animal (JM-22015) exhibited minimal perivascular
lymphohistiocytic inﬂammatory inﬁltrates in the meninges, chor-
oid plexus, cerebral gray matter and spinal cord. One animal (JM-
23228) had minimal perivascular lymphohistiocytic inﬂammatory
inﬁltrates in the brainstem and gray matter of the cervical spinal
cord. One animal (JM-24054) showed minimal perivascular
lymphocytic inﬂammatory inﬁltrates limited to the choroid plexus.
In addition, necrotizing epididymitis was present in three animals
(JM-22015, JM-23333, and JM-24054) and lymphohistiocytic
orchitis was observed in one of these (JM-24054). No histologic
evidence of concurrent bacteremia or septicemia was observed in
any of the animals.
Detection of SHFV-infected cells in tissues of infected animals
Evidence of virus replication in PBMCs was detected through-
out the course of the infection (Fig. 2B). To determine whether
virus replication was also occurring in other tissues when severe
disease signs were observed, liver and spleen tissues were
obtained from each animal at necropsy and 5 μm thick sections
were prepared and processed for antigen detection as described in
Materials and methods. Infected cells were detected with rabbit
antibodies generated against peptides from either SHFV
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nonstructural protein nsp1β or nsp1γ (Vatter et al., 2014). Anti-
CD68 antibody was used to detect macrophage/monocytes. Some
CD68-positive cells but no viral antibody positive cells were
detected in tissue sections from a control animal. Cells that were
positive for both CD68 and viral antigen were detected in liver and
spleen tissue sections from infected animals (Fig. 4). Viral antigen
was located in the cytoplasm. Not all of the CD68 cells detected
were SHFV-positive. The results indicate that tissue associated,
SHFV-infected MΦs are still present after animals develop severe
hemorrhagic fever disease.
Analysis of immune cell populations
Immunosuppression as indicated by decreases in various lym-
phocyte cell populations in the blood between 2 and 9 days after
infection was previously reported in SHFV LVR-infected macaques
Fig. 3. Gross and microscopic lesions of SHF. (A) Spleen, cut surface (JM-24054). White pulp is markedly diminished within diffusely expanded red pulp, bar¼1 cm.
(B) Duodenum (JM-22015). The mucosa exhibits ecchymotic to diffuse hemorrhage that extends to the pyloric valve, bar¼1 cm. (C) Thymus stained with H&E (JM-24054).
There is diffuse lymphocyte necrosis of cortical lymphocytes (asterisk) and depletion of medullary lymphocytes (arrow), bar¼200 μm. (D) Spleen stained with H&E (JM-
24054). Depleted and necrotic follicles are rimmed with a zone of hemorrhage. Red pulp is markedly expanded (arrow), bar¼1 mm. (E) Spleen stained with H&E (JM-24054).
A splenic follicle exhibiting lymphocyte necrosis within the central portion of the germinal center, the mantle and marginal zones with an adjacent rim of hemorrhage
(arrow), bar¼200 μm. (F) Spleen (JM- 24054). Splenic red pulp is ﬁlled with abundant ﬁbrin strands stained purple by phosphotungstic acid hematoxylin (arrows),
bar¼20 μm.
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(Johnson et al., 2011). Lymphocyte subpopulations in PBMCs
collected from each of the SHFV B11661-infected JMs at different
times post-infection were quantiﬁed by ﬂow cytometry. In all four
animals, the PBMC CD4þ , CD8þ , CD14þ and CD20þ cell popula-
tions decreased between 2 and 6 dpi compared to the levels
present in each animal prior to infection (Fig. 5). Thereafter, the
number of CD4þ and CD8þ cells increased in all four animals.
Only a transient increase in the CD14þ and CD20þ populations
was observed. The observed decrease in each of the PBMC cell
populations starting at 2 dpi in all four animals is consistent with
the development of an immunosuppressive state.
Discussion
Viruses in multiple RNA virus families, such as Filoviridae,
Arenaviridae, Bunyaviridae, and Flaviviridae, can induce viral
hemorrhagic fever disease in humans (Johnson et al., 2011). Due
to the high human morbidity caused by these viruses, including
the Filoviruses, Ebola and Marburg, experiments to elucidate how
these viruses cause disease must be performed under high con-
tainment conditions in suitable animal models. Both macaque and
mouse models have been developed for Ebola and Marburg,
(Geisbert et al., 2003a; Mahanty and Bray, 2004; Bradfute et al.,
2012). In the cynomolgus macaque-Zaire Ebola virus model dis-
ease kinetics are accelerated and infections are uniformly fatal,
compared to those of Zaire Ebola infections in humans, which can
incubate for three weeks and are not fatal in all infected indivi-
duals (Mahanty and Bray, 2004). Disease in both NHPs and
humans is associated with viral induced suppression of the hosts'
innate and adaptive immune response and increased survival in
humans is correlated with the hosts' ability to minimize the
negative effects of the virus infection on these responses.
Our data from SHFV-infected macaques provides multiple
similarities to Ebola virus induced hemorrhagic disease. Infection
of macaques with small doses of Zaire Ebola typically induces
fever by 3–4 days, hemorrhagic fever disease signs by 5–6 days,
and morbidity by 7–8 days. Similar disease induction kinetics and
a similar progression of disease parameters were observed in the
SHFV-infected macaques. The primary target cells of both Ebola
virus and SHFV in macaques are MΦs and DCs (Geisbert et al.,
2003c; Vatter and Brinton, 2014). At late times of infection, Ebola
virus also infects parenchymal cells, hepatocytes, adrenal cortical
cells and ﬁbroblasts (Bray and Mahanty, 2003; Mahanty and Bray,
2004). Although SHFV-infected MΦs were present in the livers
and spleens of moribund animals, adjacent cells in these organs
were not positive for viral antigen. The similar kinetics of severe
disease development observed in Ebola virus and SHFV-infected
Anti-Nsp1 γ Anti-CD68   Hoechst
40x20x
SHFV-infected JM-24054 liverJM-22774 control liver
Anti-Nsp1 β Anti-CD68 Hoechst 
40x40x
JM-22774 control spleen SHFV-infected JM-23228 spleen
Fig. 4. Detection of SHFV-infected cells in tissues from SHFV-infected and control Japanese macaques by immunoﬂuorescence. Post-mortem tissue was obtained, formalin-
ﬁxed and embedded in parafﬁn. Sections (5 μm thick) were cut, processed as described in Materials and methods and incubated with a rabbit antibody to SHFV nsp1β or
nsp1γ, then biotinylated goat anti-rabbit antibody and then streptavidin Alexa Fluor 488. Next, the sections were incubated with a mouse anti-CD68 antibody, then a
biotinylated goat anti-mouse secondary antibody and then streptavidin Alexa Fluor 594. Nuclei were visualized with Hoechst 33258 staining. Cells were visualized using a
Zeiss Axioscope 2 plus microscope equipped with a digital camera. Thin green arrows indicate cells detected by both anti-SHFV nonstructural protein and anti-CD68
antibodies. Thick white arrows indicate cells detected only by anti-CD68 antibody. The objective used to capture the image is indicated in the upper left corner, bars¼10 μm.
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macaques indicates that infection of additional types of cells is not
required for induction of morbidity.
Several Ebola viral proteins suppress Type I IFN production
(Zampieri et al., 2007; Chang et al., 2009). Both the transient peak
of INFα detected in the plasma at 2 days after SHFV infection and
the delayed upregulation of IFNβ mRNA in PBMCs are consistent
with recent data showing that all three of the SHFV nonstructural
protein 1s have Type 1 IFN suppressive activity (Han et al., 2014).
Ebola virus infected MΦs and DCs produce proinﬂammatory
cytokines, chemokines and tissue factor that induce vasodilation,
increase vascular permeability and disseminated intravascular
coagulation (Geisbert et al., 2003d; Bray and Geisbert, 2005).
Pro-inﬂammatory cytokines also cause bystander lymphocyte
apoptosis in Ebola virus infected macaques (Geisbert et al.,
2003b; Ruf, 2004; Bray, 2005). SHFV-infection of cultured maca-
que MΦs and myloid DCs induces proinﬂammatory cytokines
(Vatter and Brinton, 2014) and proinﬂammatory cytokine produc-
tion, decreased PBMC lymphocyte populations and tissue lympho-
cyte necrosis were detected in all four of the JMs infected with
SHFV. Neither Ebola virus nor SHFV can infect lymphocytes,
implying that the two viruses induce lymphocytosis by related
indirect mechanisms. Although CD4þ and CD8þ cell populations
were decreased in all four SHFV- infected animals between days
2 and 6 after infection, cell numbers increased thereafter suggest-
ing the activation of an adaptive immune response. Humans who
mount a rapid and robust immune response can survive an Ebola
virus infection (Mahanty and Bray, 2004) and therapeutic recom-
binant antibodies as well as transfusions from Ebola survivors
have enhanced patient survival. However, if an immune response
was initiated in the SHFV infected macaques, it did not alter the
progression of hemorrhagic fever disease.
Although it was previously estimated that 1% of baboons, 1%
of African green monkeys and 10% of patas monkeys are SHFV-
positive (London, 1977), the numbers and histories of the animals
tested to obtain these estimates and which available biological test
(macaque infection, cytopathic infection of macaque MΦ cultures
or cytopathic infection in MA104 cells) was used were not
reported. In the present study, a total of 205 baboons from a
colony in the USA were tested for SHFV using RT-PCR assays
targeting two conserved regions of the SHFV genome. These assays
provided a sensitive and consistent method for detecting persis-
tently infected animals. The data obtained from archived samples
from wild-caught Olive baboons introduced into the colony over a
16 year period indicated that 14.2% not 1% of these animals were
infected with SHFV. However, because blood samples obtained at
the time of capture were not available for any of the wild-caught
animals, it could not be determined whether these animals were
infected in the wild or after capture. The percentage of opportu-
nistically sampled animals living in the colony that were SHFV
positive was 19% which was also much higher than 1%. However,
the majority of the colony animals that were sampled were males
that were in the clinic for treatment of lacerations obtained during
ﬁghting and this percentage is therefore expected to be higher
than that for the entire colony. Multiple baboon species as well as
hybrid animals in the colony were found to be SHFV positive. The
data obtained on the colony-bred animals clearly indicated that
SHFV continues to be transmitted between animals after intro-
duction into a captive baboon colony. Additional species of African
NHPs, red colobus (Procolobus rufomitratus tephrosceles) and red-
tailed guenons (Cercopithecus ascanius) were recently reported to
be infected with SHFV in the wild (Lauck et al., 2013; Bailey et al.,
2014). The sequences of these SHFV isolates are divergent from
LVR and whether they can infect macaques and cause hemorrhagic
fever disease is not known.
A single previous study reported that patas monkeys could
remain SHFV positive for up to 13 years as indicated by detection
of antibody to puriﬁed SHFV LVR in an ELISA (Gravell et al., 1986).
The duration of persistent SHFV infections in baboons had not
previously been tested. Baboons in the present study were also
found to remain SHFV-positive for at least 10 years. Data from
SHFV RT-PCR assays done on serially diluted sera from persistently
infected baboons indicated that the viremia levels in these animals
Fig. 5. -PBMCs collected prior to or on the day of infection and either every day or every other day after SHFV infection were stained with the indicated cell surface marker
and the number of positive cells was quantiﬁed by ﬂow cytometry.
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are low (100 to 1000 genome copies/ml) and SHFV was also
reported to grow to low titers in baboon MΦs and mDCs (Vatter
and Brinton, 2014). Attempts to sequence SHFV genome RNA
directly from baboon plasma by 454 sequencing yielded only
short contigs representing 15% or less of the genome. However,
nearly complete sequences were obtained from virus that was
ampliﬁed by a single passage in rhesus macaque MΦ cultures. The
single passage in macaque MΦ may have selected for a virus
subpopulation that can efﬁciently infect and replicate in macaque
MΦs and therefore the full diversity of the virus populations in the
persistently infected animals was not analyzed. Baboons B11661
and B11662 were housed together only in the early 1990s and it is
possible that one infected the other. However, it was still surpris-
ing that the genome sequences obtained for the SHFV isolates
from these two long term (410 years) persistently infected
baboons were so similar to each other and even more surprising
that these sequences were also very similar to the sequence of
SHFV LVR (AF180391.2) (Vatter et al., 2014), which was isolated in
1964 (Tauraso et al., 1968). Although coronavirus genomes encode
proofreading enzymes, arterivirus genomes do not (Denison et al.,
2011). A major contributing factor to the low sequence divergence
observed for the baboon and LVR SHFV isolates may be the low
level of virus replication in the target cells in these animals (Vatter
and Brinton, 2014).
In experimental SHFV infection studies done in the 1960s,
inoculation of low doses of SHFV from infected macaque serum
by the intramuscular route consistently induced severe hemor-
rhagic disease in macaques (Palmer et al., 1968; Tauraso et al.,
1968). In contrast, in a 2011 study, no correlation between SHFV
LVR dose (50–500,000 PFU) and hemorrhagic disease induction
was observed (Johnson et al., 2011). The LVR used in the 2011
study was generated by three freeze–thaw cycles of infected
MA104 cells. The large amount of cell and viral RNA present in
these lysates would be expected to activate cell RNA sensors and
strongly induce the host antiviral response which may have
contributed to the decreased efﬁciency of hemorrhagic disease
induction observed. It is also possible that defective SHFV gen-
omes present in the inoculum may have reduced the efﬁciency of
virus replication. In the present study, baboon SHFV in culture
ﬂuid from primary macaque MΦs was diluted in PBS and animals
were injected with 100 PFU by the intravenous route. This inocu-
lation route was chosen because it closely approximates natural
transmission conditions and was expected to facilitate efﬁcient
infection of peripheral MΦs and DCs. Consistent hemorrhagic
disease induction with similar kinetics of viremia, of proinﬂam-
matory cytokine production, and of hemorrhagic disease develop-
ment was observed in all of the animals tested. Virus titers in
blood and viral RNA levels in PBMCs remained high throughout
the course of the infection. No evidence of bacterial sepsis was
observed in any of the SHFV-infected JMs in the present study.
Three of the four animals were treated with antibiotics as a
precaution. The only effect of providing antibiotics and supportive
care to SHFV-infected rhesus macaques observed during 1960s
epizootics “was a shortening of the course of the hemorrhagic
disease resulting in earlier death” (Allen et al., 1968). The con-
sistent induction of severe hemorrhagic disease with similar
kinetics achieved in macaques after inoculation of a low dose of
a baboon isolate of SHFV indicates that this represents an
improved BSL2 model of viral hemorrhagic fever disease for
studying viral and host factors controlling disease severity. The
availability of multiple animal models of viral hemorrhagic fever is
expected to facilitate the development of broad based therapeutics
to treat disease complications associated with hemorrhage and
coagulation disorders. As has become evident during the recent
Ebola outbreak in Africa, there is an urgent need for therapies
targeting hemorrhagic disease complications for use in
combination with virus-speciﬁc therapies to enhance the chance
of patient recovery.
Materials and methods
Cells
MA104 cells obtained from O. Nainin (Centers for Disease
Control and Prevention) were grown in minimum essential med-
ium (MEM) supplemented with 10% FBS, 1% L-glutamine and 1%
gentamicin at 37 1C in 5% CO2. Whole blood collected in acid
citrate dextrose (ACD) BD Vacutainers collection tubes (BD
Bioscience) from rhesus macaques (Yerkes Regional Primate
Research Center) was used to isolate peripheral blood mono-
nuclear cells (PBMCs) by Ficolls 400 (Mediatech Inc.) density
gradient centrifugation according to standard protocols. Mono-
cytes were seeded at 106 cells/well in 24-well plates and allowed
to adhere for 1 h before gentle washing with Hanks buffered saline
solution. MΦs were differentiated from adherent cells by incuba-
tion with RPMI-1640 culture media supplemented with 10%
autologous serum or 10% heat-inactivated FBS, 50 U/ml of peni-
cillin, 50 μg/ml of streptomycin, 5000 U/ml human recombinant
MΦ colony stimulating factor (R&D Systems) for 11 days at 37 1C
in 5% CO2. During differentiation, two-thirds of the culture media
was replaced with fresh growth media every three days to
replenish growth factors. To conﬁrm the identity of the differ-
entiated cells, cells were stained with ﬂuorescently-labeled anti-
bodies directed against the MΦ surface markers CD91 and CD163
(BD Bioscience) and then sorted and enumerated using a FACS-
Canto ﬂow cytometer and FACSDiva software (BD Bioscience).
Greater than 95% of cells in MΦ cultures were CD91þ and
CD163þ .
Virus
An aliquot of SHFV, strain LVR 42-0/M6941, was obtained from
American Type Culture Collection. Analysis of virion RNA from an
initial passage in MA104 cells (peak titer 105 PFU/ml) by gel
electrophoresis detected the genome as well as several strong
bands that were shorter than genome length (Brinton, unpub-
lished data). The virus was serially plaque puriﬁed three times on
MA104 cells and then ampliﬁed once on a MA104 cell monolayer
(MOI of 0.01) to produce a stock pool. Pools of SHFV-LVR used for
experiments were prepared by infecting conﬂuent MA104 mono-
layers with the stock pool at an MOI of 0.2. Culture media was
harvested at 32 h after infection, clariﬁed, aliquoted and stored at
80 1C (titer 107 PFU/ml).
The baboon SHFV isolates were ampliﬁed by a single passage
on primary macaque MΦ cultures. Serum was collected in clot
tubes (BD Bioscience) at Southwest National Primate Research
Center. MΦ cultures prepared as described above in wells of a 24
well plate were incubated with 200 ml of baboon serum at 37 1C in
5% CO2 for 1 h. After virus adsorption, cells were washed and then
culture ﬂuid was harvested at 120 h after infection (titer
103-4 PFU/ml).
Plaque assay
SHFV infectivity was quantiﬁed by plaque assay on conﬂuent
monolayers of MA104 cells in six-well plates. After adsorption for
1 h at room temperature, the virus inoculumwas removed and the
wells were overlaid with 1% SeaKem ME agarose (Bio-Whittaker
Molecular Applications) mixed 1:1 with 2X MEM containing 5%
FCS, and incubated at 37 1C for 72 h. After removal of the agarose
plug, cells were stained with 0.05% crystal violet in 70% ethanol.
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SHFV one-step RT-PCR assays
Archived serum samples collected from baboon colony animals
at the Southwest National Primate Research Center were shipped
on dry ice overnight to Georgia State University. To obtain plasma,
blood samples from baboons were collected in ACD tubes at
Southwest National Primate Research Center and shipped at room
temperature overnight to Georgia State University. Plasma and
serum were stored at 80 1C. RNA was isolated from 100 ml of
plasma or an archived serum aliquot with TRIZOL Reagent LS
(Molecular Research Center, Inc.) according to manufacturer's
protocol and used as template for RT-PCR. Pairs of primers from
either the nucleocapsid (forward primer, 50-GGCAAACCAAAAC-
CAAATAACAAGGG-30 and reverse primer, 50-ATAAT-
CAGTGTCTGGCCTAGGTGG-30) or the helicase (forward primer, 50-
CTCTGTCTAACTTTGTGGTGGG-30 and reverse primer, 50-
TTTGCGAGCTGATGATGCGGG-30) regions of the genome were
designed based on the SHFV-LVR Genbank sequence (accession
number AF180391.2). SHFV RNA was ampliﬁed using the Super-
Scripts III One-Step RT-PCR system with Platinums Taq High
Fidelity (Invitrogen). The cycling parameters were RT at 48 1C for
30 min, denaturation at 941 for 2 min, 37 cycles of denaturation at
94 1C for 30 s, annealing at 55 1C for 30 s and elongation at 68 1C
for 30 s. The resulting DNA was electrophoresed on a 1% agarose
gel containing ethidium bromide in TBE buffer (90 mM Tris,
90 mM boric acid and 2 mM EDTA, pH 8.0) and visualized with a
LAS3000 Luminescent Image Analyzer (GE Healthcare).
454 sequencing of baboon SHFV genome RNA
Diluted baboon serum or culture ﬂuid containing a baboon
SHFV was passed through a 0.45 μm ﬁlter, centrifuged at
50,000 Xg for 2 h, and the pellet was resuspended in PBS overnight
at 4 1C and then treated with DNase Turbo, Benzonase, and RNase
One for 2 h at 37 1C to remove any “free” RNA and DNA. A Qiagen
Viral RNA kit (Qiagen, Valencia, CA) was used to extract virion RNA
that was then reverse transcribed, puriﬁed, and ampliﬁed as
described previously (Donaldson et al., 2010; Vatter et al., 2014).
Brieﬂy, the RNA was reverse transcribed with Superscript III (Life
Technologies, Grand Island, NY) using random hexamers with a
unique barcode, dsDNA was generated from the cDNA in a Klenow
reaction and the dsDNAwas then incubated with phosphatase and
exonuclease. A 10 ml aliquot of the Klenow reaction was used as
template for random ampliﬁcation using a unique barcode, with-
out the random hexamer portion, as a primer. The DNA was gel
puriﬁed using a QiaQuick Gel Extraction Kit (Qiagen, Valencia, CA)
and submitted to the University of North Carolina High Through-
put Sequencing facility for sequencing using the Roche 454 Life
Science FLX Titanium chemistry (454 Life Sciences of Roche,
Branford, CT) for the ﬁrst sequence run. The second sequence
run used the Roche 454 Junior platform and chemistry (454 Life
Sciences of Roche, Branford, CT).
The sequences obtained were binned based on the barcode
sequence added, and the barcode sequences were trimmed from
the reads in each unique bin, representing individual samples.
Each sample bin was mapped to the SHFV reference genome
(Accession no. AF180391.2) using the CLC Genomics Workbench
version 5.1 default settings (CLCBio, Aarhus, Denmark). The 50%
majority rule was used to determine consensus sequences for each
contig. De novo assembly of each 454 sequence bin was also done
to determine whether the approaches produced similar results
and to detect sequences of unknown identity. The de novo
assembly consensus sequences derived were then used to query
the non-redundant nucleotide database using BLAST within the
CLC Genomics Workbench interface. Annotation of differences
between the reference genome and the genome derived by
sequencing was done by a multiple sequence alignment generated
with CLC Genomics Workbench.
Experimental infection and evaluation of SHFV- infected macaques
All aspects of the experimental animal infection studies were
performed according to the Institutional Guidelines for Animal
Care and Use at the Oregon National Primate Research Center,
Beaverton, OR. Four adult (9–12 years old) male Old World
Japanese macaques (M. fuscata) were inoculated intravenously
with 100 PFU of macaque MΦ-ampliﬁed, baboon SHFV isolate
B11661 and evaluated by physical examination on a daily basis by
a clinical veterinarian. A clinical score sheet was designed that was
similar to one previously described (Johnson et al., 2011) with ﬁve
clinical categories to assess the disease course. Parameters
included overall clinical appearance, respiratory abnormalities,
activity levels and species-speciﬁc behavior, responsiveness, and
core body temperature. Each category contained ratings of 0–10,
with 0 as normal and 10 being severe. Animals were euthanized
when their combined clinical assessment scores reached 10. Blood
samples were taken daily (ﬁrst cohort) or every other day (second
cohort) and plasma and PBMCs were used for the assays described
below. A complete necropsy was performed on each animal.
Samples were collected from a standard list of tissues, ﬁxed in
10% neutral-buffered formalin, and prepared for histopathological
and immunohistochemical evaluation.
Quantiﬁcation of cell IFNβ mRNA and viral mRNA by quantitative
real-time RT-PCR (qRT-PCR)
Total cellular RNA from an aliquot of PBMCs was isolated using
an RNeasy Mini kit (Qiagen) according to the manufacturer's
protocol. The primer mix and TaqMan MGB probe used to detect
rhesus macaque IFNβ mRNA was IFNβ Rh03648734_s1 (Applied
Biosystems). qRT-PCR was performed for the target gene mRNA
and for the endogenous control (eukaryotic 18S rRNA VIC/TAMRA
dye labeled, Applied Biosystems) in a single-plex format with
100 ng of cellular RNA and the TaqMan one-step RT-PCR master
mix reagent kit (Applied Biosystems). The cycling parameters were
48 1C for 30 min, 95 1C for 10 min, and 40 cycles of 95 1C for 15 s
and then 60 1C for 1 min on an Applied Biosystems 7500 sequence
detection system. Each sample was assayed in triplicate. The
triplicate Ct values were analyzed with Microsoft Excel using the
comparative Ct (ΔΔCt) method of the SDS Applied Biosystems
software which also applied statistical analysis to the data (TINV
test in Microsoft Excel). The values were normalized to those for
18S rRNA in the same sample and are the relative fold change
compared to the mock infected 24 h calibrator sample value in
relative quantiﬁcation units (RQUs). Error bars represent the
standard error of the mean and indicate the calculated minimum
(RQmin) and maximum (RQmax) of the mRNA expression levels
based on an RQmin/max of the 95% conﬁdence level.
A primer-probe set targeting the nucleocapsid region of SHFV
was designed from the SHFV-LVR Genbank consensus sequence.
The primer sequences were as follows: Forward primer 50-
TCCCACCTCAGCACACATCA-30; TaqMan probe 50-6FAM-AACAGCTG
CTGATCAGGT-MGBNFQ-30; reverse primer 50-CCGCCTCC
GTTGTCGTAGT-30. Total cellular RNA from SHFV-infected PBMCs
was isolated with TRI Reagent (Molecular Research Center, Inc.)
according to the manufacturer's protocol. Total cellular RNA
(100 ng) was used for one-step qRT-PCR to quantify viral RNA or
18S rRNA (eukaryotic 18S rRNA VIC/TAMRA dye labeled, Applied
Biosystems) with the TaqMan one-step RT-PCR master mix reagent
kit (Applied Biosystems) using gene speciﬁc 20X primer mixes and
TaqMan MGB probes. The cycling parameters were RT at 48 1C for
30 min, AmpliTaq activation at 95 1C for 10 min, denaturation at
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95 1C for 15 s and annealing/extension at 60 1C for 1 min (repeated
40 times). RNA was quantiﬁed with an Applied Biosystems 7500
sequence detection system. Triplicate Ct values were analyzed by
the comparative Ct (ΔΔCt) method (Applied Biosystems). The
amount of target (2ΔΔCt) was determined by normalization to an
endogenous control (18S rRNA) in each sample and relative to a
calibrator sample (day 0). Intracellular SHFV RNA was quantiﬁed
using a standard curve generated with 10-fold serial dilutions of a
known concentration of SHFV RNA in vitro transcribed with an SP6
mMessage mMachine kit (Ambion) from a SHFV cDNA template.
After in vitro transcription, the DNA template was digested with
Turbo DNase at 37 1C for 5 min. The RNA was puriﬁed with lithium
chloride, precipitated with ethanol, washed with 70% ethanol,
resuspended in RNase-free water, and quantiﬁed by UV spectro-
photometry. The data obtained were used to calculate viral RNA
copy number.
Quantiﬁcation of secreted cytokines
Pro-inﬂammatory cytokines in macaque plasma were quanti-
ﬁed using a Luminex microsphere based ELISA as previously
described (Hutchinson et al., 2001; Vatter and Brinton, 2014).
Brieﬂy, polyclonal antibodies (Table 3) were conjugated to poly-
styrene xMAP microspheres (Luminex Corp.) using an xMAP anti-
body coupling kit (Luminex Corp.). One hundred microspheres for
each analyte were then incubated with 25 ml of plasma at 4 1C for
16 h. Microspheres incubated with 25 ml of each of the serially
diluted human recombinant cytokines were used to construct
standard curves (from 400 pg/ml to 0.128 pg/ml). Microspheres
were washed thrice in PBS containing 1% BSA and then incubated
with one of the analyte-speciﬁc, biotinylated antibodies at 25 1C
for 1 h. Microspheres were washed thrice in 1% BSA-PBS and then
incubated with 5 mg/ml streptavidin-R-phycoerythrin (Sigma-
Aldrich) at 25 1C for 30 min. Microspheres were washed thrice in
1% BSA-PBS, resuspended in Luminex xMAP systems ﬂuid and
analyzed using a Luminex 100 analyzer (Qiagen).
Western blotting
PBMC aliquots were lysed in RIPA buffer (1X phosphate-
buffered saline, 1% Nonidet P-40, 0.5% sodium deoxycholate and
0.1% SDS) containing Halt protease inhibitor cocktail (Thermo
Scientiﬁc). Following separation by 10% SDS-PAGE, proteins were
electrophoretically transferred to a nitrocellulose membrane.
Membranes were blocked with 1X TBS containing 5% non-fat dry
milk and 0.1% Tween 20 before incubation with a 1:1000 dilution
of sheep anti-human tissue factor antibody (Cedarlane Labs) in the
presence of blocking buffer. Actin was used as a loading control
and was detected with a 1:20,000 dilution of antibody C-11 (Santa
Cruz Biotechnology). Blots were washed with 1X TBS containing
0.1% Tween-20 and incubated with a 1:2000 dilution of secondary
antibody (horseradish peroxidase-conjugated anti-sheep or anti-
mouse; Santa Cruz). Washed blots were then processed for
chemiluminescence using a Super-Signal West Pico detection kit
(Pierce Scientiﬁc) according to manufacturer's protocol.
Detection of SHFV-infected cells in tissues of infected macaques
Samples obtained from tissue collected at necropsy from SHFV-
infected Japanese macaques were incubated in 10% neutral buf-
fered formalin for 48 h and then transferred to 70% ethanol for
further processing. The samples were then embedded in parafﬁn
and cut into 5 μm thick sections. The sections were mounted onto
slides, deparafﬁnized and hydrated. The sections were then
incubated with 5% bovine serum albumin and 10% goat serum
and Avidin/Biotin Blocking Kit buffer (Vector Laboratories) to block
endogenous biotin and biotin receptors and avidin binding sites
present in tissues. Endogenous peroxidase was quenched by
standard techniques. Tissue sections were ﬁrst incubated with
rabbit polyclonal anti-nsp1β or anti-nap1γ antibody diluted 1:500
in antibody diluent (DAKO) overnight at 4 1C and then with
biotinylated goat anti-rabbit antibody (Vector Laboratories) for
30 m at room temperature. After washing, the sections were
incubated for 30 m with peroxidase ABC (Vector Laboratories)
and thenwith streptavidin Alexa Fluor 488 (Invitrogen) for 30 m at
room temperature. After washing, the sections were blocked with
5% bovine serum albumin and 10% goat serum and then incubated
with anti-MΦ antibody (mouse anti-CD68, DAKO) diluted 1:80
overnight at 4 1C in antibody diluent (DAKO). Detection of bioti-
nylated goat anti-mouse secondary antibody was performed with
ABC (Vector Laboratories) and incubated with streptavidin Alexa
Fluor 594 (Invitrogen) for 30 m at room temperature. Sections
were stained with Hoechst 33258 dye (Sigma-Aldrich) to visualize
nuclei. Stained slides were covered with prolong gold imaging
medium (Invitrogen). Images were acquired using a ﬂuorescence
microscope (Zeiss Axioscope 2 plus microscope, Carl Zeiss Micro-
imaging Inc.) equipped with a digital camera (Zeiss Axio-Cam) and
ﬁlter cubes were used to document speciﬁc Alexa 488, Alexa 594
and Hoechst ﬂuorescence. Mouse IgG1 isotype (R&D Systems,
Minneapolis, MN) was used as an isotype control antibody and
did not give a positive signal on tissue from infected animals (data
not shown).
Flow cytometry analysis of PBMCs
Prior to experimental SHFV inoculation, blood and lymph node
biopsies were collected from each animal to serve as pre-infection
control samples. Following infection, blood samples were collected
daily (ﬁrst cohort of two animals) or every other day (second
cohort of two animals) to obtain plasma and PBMCs. PBMCs were
stained for cell surface markers CD4 (eBioscience) or CD8b (Beck-
man Coulter) to identify CD4þ and CD8þ T cell subsets, respec-
tively, as well as CD20 (Biolegend) to identify B cells and CD14
(Biolegend) to identify monocytes. Samples were analyzed using
an LSRII instrument (BD) and the data obtained were analyzed
using FlowJo software (TreeStar). Total blood cell counts were
obtained to determine the number of peripheral lymphocytes of
each class for each animal.
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